These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5883401)

  • 1. Therapeutic possibilities of minor antibacterial drugs against infections with Mycobacterium tuberculosis.
    Radenbach KL
    Antimicrob Agents Chemother (Bethesda); 1965; 5():1065-73. PubMed ID: 5883401
    [No Abstract]   [Full Text] [Related]  

  • 2. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy.
    Ji B; Grosset JH
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S45-55. PubMed ID: 10700937
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential of azole antifungals against latent/persistent tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 May; 258(2):200-3. PubMed ID: 16640573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 6. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    Di Perri G; Bonora S
    J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2007 Mar; 5(55):15-22. PubMed ID: 17325626
    [No Abstract]   [Full Text] [Related]  

  • 8. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980].
    Szczuka I
    Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current drugs against tuberculosis].
    Roosenburg JG
    Ned Tijdschr Geneeskd; 1976 Feb; 120(6):241-6. PubMed ID: 1250461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis].
    Xu G; Li H; Liu S
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium on antimicrobial therapy. XI. Antituberculosis agents.
    Greenfield RA; Muchmore HG
    J Okla State Med Assoc; 1993 Aug; 86(8):375-82. PubMed ID: 8229363
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drugs against tuberculosis and nontuberculous mycobacterial infections: a review].
    Amitani R; Kuze F
    Kekkaku; 1994 Nov; 69(11):711-7. PubMed ID: 7837725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting tuberculosis: old drugs, new formulations.
    Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
    Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of tuberculosis in Denmark].
    Heckscher T; Viskum K
    Ugeskr Laeger; 1981 Feb; 143(7):423. PubMed ID: 7281349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.